Table 1 |
||||||
|
Results of VaxGen HIV vaccine trial |
||||||
|
total |
vaccine |
placebo |
RR |
|||
|
|
|
|
|
|||
|
subjects |
subjects |
incidence |
subjects |
incidence |
||
|
|
||||||
|
white |
4511 |
3003 |
179 |
1508 |
81 |
1.11 |
|
nonwhite |
498 |
327 |
12 |
171 |
17 |
0.37 |
|
black |
314 |
203 |
4 |
111 |
9 |
0.24 |
|
Asian |
73 |
53 |
2 |
20 |
2 |
0.38 |
|
other |
111 |
71 |
6 |
40 |
6 |
0.56 |
|
total |
5009 |
3330 |
191 |
1679 |
98 |
0.98 |
|
|
||||||
|
Source: The New York Times [7] and author's calculations. |
||||||
|
Phillips BMC Medical Research Methodology 2004 4:20 doi:10.1186/1471-2288-4-20 |
||||||